| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 181.819 | 176.290 | 116.558 | 108.296 | 75.670 | 84.252 | 25.654 | 23.033 | 17.157 | 20.806 |
| Total Income - EUR | 234.204 | 224.684 | 123.471 | 123.344 | 149.011 | 87.892 | 34.597 | 31.803 | 18.876 | 20.806 |
| Total Expenses - EUR | 231.649 | 208.957 | 120.863 | 112.037 | 146.857 | 86.566 | 51.555 | 29.561 | 17.566 | 34.371 |
| Gross Profit/Loss - EUR | 2.556 | 15.727 | 2.608 | 11.307 | 2.154 | 1.326 | -16.958 | 2.242 | 1.310 | -13.565 |
| Net Profit/Loss - EUR | 2.119 | 13.225 | 356 | 9.792 | 1.709 | 716 | -16.958 | 1.308 | 596 | -14.344 |
| Employees | 8 | 7 | 3 | 4 | 3 | 2 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Vademecum-Comserv Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 48.277 | 42.705 | 32.432 | 21.578 | 14.212 | 15.903 | 288 | 278 | 36.970 | 27.639 |
| Current Assets | 70.917 | 70.139 | 57.682 | 45.080 | 48.346 | 68.938 | 46.216 | 12.502 | 13.978 | 11.419 |
| Inventories | 57.438 | 59.712 | 45.538 | 36.097 | 40.241 | 39.531 | 14.987 | 141 | 10 | 1.073 |
| Receivables | 9.492 | 8.535 | 11.133 | 8.507 | 6.516 | 4.323 | 12.524 | 12.201 | 12.860 | 11.620 |
| Cash | 3.971 | 1.877 | 995 | 461 | 1.574 | 25.070 | 18.704 | 161 | 1.108 | -1.274 |
| Shareholders Funds | 33.856 | 35.251 | 10.215 | 19.820 | 22.468 | 22.758 | 5.296 | 6.619 | 7.195 | -7.189 |
| Social Capital | 45 | 45 | 9.851 | 9.670 | 9.483 | 9.303 | 9.097 | 9.125 | 9.097 | 9.046 |
| Debts | 62.313 | 77.769 | 80.194 | 47.056 | 40.305 | 62.399 | 41.211 | 6.310 | 43.756 | 46.440 |
| Income in Advance | 23.024 | 5.606 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4762 - 4762" | |||||||||
| CAEN Financial Year |
4761
|
|||||||||
Comments - Vademecum-Comserv Srl